Beta-blocker under-use in COPD patients

References

• World Health Organization FactsheetChronic obstructive pulmonary disease (COPD); Fact sheet112016 Available at: http://www.who.int/mediacentre/factsheets/fs315/en/Accessed March 23, 2017
   Google Scholar
• GroenewegenKHScholsAMWoutersEFMortality and mortality-related factors after hospitalization for acute exacerbation of COPDChest2003124245946712907529
   PubMed Web of Science ®Google Scholar
• AlmagroPCalboEOchoa de EchagüenAMortality after hospitalization for COPDChest20021211441144812006426
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJMartínez-GarcíaMÁRomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax20056092593116055622
   PubMed Web of Science ®Google Scholar
• FabbriLMLuppiFBegheBRabeKFComplex chronic comorbidities of COPDEur Respir J20083120421218166598
   PubMed Web of Science ®Google Scholar
• SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest200512842099210716236861
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global strategy for diagnosis, management, and prevention of COPD2016 Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/Accessed January 18, 2016
   Google Scholar
• SmithMCWrobelJPEpidemiology and clinical impact of major comorbidities in patients with COPDInt J COPD20149871888
   Google Scholar
• MillerJEdwardsLDAgustíAfor ECLIPSE investigatorsComorbidity, systemic inflammation and outcomes in the ECLIPSE cohortRespir Med20131071376138423791463
   PubMed Web of Science ®Google Scholar
• DivoMCoteCde TorresJPfor BODE Collaborative GroupComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
   PubMed Web of Science ®Google Scholar
• GottliebSSMcCarterRJVogelRAEffect of beta-blockade of mortality among high-risk and low-risk patients after myocardial infarctionN Engl J Med199833984894979709041
   PubMed Web of Science ®Google Scholar
• HawkinsNMHuangZPieperKSChronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartain in Acute Myocardial Infarction Trial (VALIANT)Eur J Heart Fail200911329229819176539
   PubMed Web of Science ®Google Scholar
• MERIT-HF Study GroupEffect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized interventional trial in heart failure (MERIT-HF)Lancet199935391692001200710376614
   PubMed Web of Science ®Google Scholar
• PackerMFowlerMBRoeckerEBfor COPERNICUS Study GroupEffect of carvediolol on the morbidity of patients with severe chronic heart failureCirculation2002106172194219912390947
   PubMed Web of Science ®Google Scholar
• QuintJKHerrettEBhaskaranKEffect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare recordsBMJ2013347f665024270505
   PubMed Web of Science ®Google Scholar
• ShortPMLipworthSWElderDHJSchembriSLipworthBJEffect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort studyBMJ2011342d254921558357
   PubMed Web of Science ®Google Scholar
• SalpeterSROrmistonTMSalpeterEECardioselective beta-blockers for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20054CD00356616235327
   PubMed Web of Science ®Google Scholar
• NeefPAMcDonaldCFBurrellLMIrvingLBJohnsonDFSteinfortDPBeta-blockers are under-prescribed in patients with chronic obstructive pulmonary disease and co-morbid cardiac diseaseIntern Med J201646111336134027813357
   PubMed Web of Science ®Google Scholar
• HarrisonMTShortPWilliamsonPASinganayagamAChalm-ersJDSchembriSThrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapyThorax201469760961524743560
   PubMed Web of Science ®Google Scholar
• DonaldsonGCHurstJRSmithCJHubbardRBWedzichaJAIncreased risk of myocardial infarction and stroke following exacerbation of COPDChest201013751091109720022970
   PubMed Web of Science ®Google Scholar
• MacGarveyLPJohnMAndersonJAZvarichMWiseRAAscertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint CommitteeThorax200762541141517311843
   PubMed Web of Science ®Google Scholar
• MacDonaldMIShafuddinEKingPTChangCLBardinPGHancoxRJCardiac dysfunction during exacerbations of chronic obstructive pulmonary diseaseLancet Respir Med20164213814826781000
   PubMed Web of Science ®Google Scholar
• LarattaCRvan EedenSAcute exacerbation of chronic obstructive pulmonary disease: cardiovascular linksBiomed Res Int2014201452878924724085
   PubMed Web of Science ®Google Scholar
• DransfieldMTRoweSMJohnsonJEBaileyWCGeraldLBUse of β blockers and the risk of death in hospitalized patients with acute exacerbations of COPDThorax200863430130517951276
   PubMed Web of Science ®Google Scholar
• DuQSunYDingNLuLChenYBeta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studiesPLoS One2014911e11304825427000
   PubMed Web of Science ®Google Scholar
• BhattSPConnettJEVoelkerHβ-blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βBLOCK COPD): a randomized controlled study protocolBMJ Open201666e012292
   PubMed Web of Science ®Google Scholar
• JabbourAMacdonaldPSKeoghMDifferences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trialJ Am Coll Cardiol2016551717801787
   Web of Science ®Google Scholar
• LainscakMPodbregarMKovacicDRozmanJvon HaehlingSDifferences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trialRespir Med2011105Suppl 1S44S4922015086
   PubMed Web of Science ®Google Scholar
• StefanMSRothbergMBPriyaAPekowPSAuDHLindenauerPKAssociation between beta-blocker therapy and outcomes in patients hospitalized with acute exacerbations of chornic obstructive lung disease with underlying ischemic heart disease, heart failure or hypertensionThorax2012671197798422941975
   PubMed Web of Science ®Google Scholar
• EkströmMPHermanssonABStrömKEEffects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187771572023328521
   PubMed Web of Science ®Google Scholar